Question 1

Does JPMorgan Chase own DYN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 3,151,656 shares of DYN (Dyne Therapeutics), worth $67.2M.

Question 2

How many shares of DYN does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 3,151,656 shares of DYN (Dyne Therapeutics).

Question 3

What is JPMorgan Chase's DYN position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's DYN position is worth $67.2M.

Question 4

Is JPMorgan Chase buying or selling DYN?

Accepted Answer

In Q2 2026, JPMorgan Chase reduced its DYN position by 101,817 shares (-3.1%).

Question 5

When did JPMorgan Chase first buy DYN?

Accepted Answer

JPMorgan Chase already held DYN in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	3.2M	-3.1%	$67.2M	0.0%	$22.21	0
2026-Q1	Decreased	3.3M	-8.3%	$55.6M	0.0%	$14.60	0
2025-Q4	Increased	3.5M	+5.5%	$69.4M	0.0%	$19.56	31
2025-Q3	Increased	3.4M	+9.0%	$42.6M	0.0%	$12.65	32
2025-Q2	Increased	3.1M	+21.9%	$29.4M	0.0%	$9.57	35
2025-Q1	Increased	2.5M	+2472.8%	$26.5M	0.0%	$11.45	46
2024-Q4	Decreased	98,387	-3.3%	$2.3M	0.0%	$23.56	0
2024-Q3	First report	101,750	-	$3.7M	0.0%	$35.92	0

DYN8 quarters

DYN
8 quarters